+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Vasodilative responses of coronary conduit and resistance arteries to bradykinin are preserved in patients with coronary spastic angina Comparison with acetylcholine



Vasodilative responses of coronary conduit and resistance arteries to bradykinin are preserved in patients with coronary spastic angina Comparison with acetylcholine



Circulation 98(17 SUPPL ): I404-I405, Oct 27




(PDF emailed within 1 workday: $29.90)

Accession: 034193572

Download citation: RISBibTeXText


Related references

Coronary vasomotor responses to bradykinin and acetylcholine in patients with coronary spastic angina. Japanese Circulation Journal 65(12): 1052-1056, 2002

Enhancement of constrictor response of spastic coronary arteries to acetylcholine but not to phenylephrine in patients with coronary spastic angina. Journal of Cardiovascular Pharmacology 33(3): 414-419, 1999

Preserved endothelium dependent vasodilatation of epicardial spastic site and resistance coronary arteries in patients with vasospastic angina. Japanese Circulation Journal 61(7): 632, 1997

Enhancement of constrictor response of spasm coronary arteries to acetylcholine but not to phenylephrine in patients with coronary spastic angina. Circulation 94(8 SUPPL ): I689, 1996

Intracoronary infusion of reduced glutathione attenuates constrictor response of coronary arteries to acetylcholine in patients with coronary spastic angina. Circulation 98(17 SUPPL ): I176, Oct 27, 1998

Heterogeneous vasomotor responses of conduit and resistance coronary arteries after intracoronary acetylcholine in hypertension. Journal of the American College of Cardiology 29(2 SUPPL A): 524A, 1997

High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). Journal of the American College of Cardiology 59(7): 655-662, 2012

Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. American Journal of Physiology. Heart and Circulatory Physiology 280(1): H264-H271, 2000

Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. American Journal of Physiology 280(1): 64-H271, 2001

Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. Journal of the American College of Cardiology 36(2): 432-437, 2000

Paradoxical increase in coronary flow velocity after termination of acetylcholine infusion is a marker of the impaired vasodilatation at coronary microvessels in patients with angina and normal coronary arteries. Catheterization and Cardiovascular Interventions 48(2): 170-177, 1999

NO-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. Circulation 94(8 SUPPL ): I689, 1996

Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina. American Journal of Cardiology 79(5): 606-610, 1997

Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. Journal of the American College of Cardiology 32(1): 103-109, 1998

Vitamin C improves the abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. Circulation 96(8 SUPPL ): I761, 10/21/97, 1997